0001065544-17-000001.txt : 20171010 0001065544-17-000001.hdr.sgml : 20171010 20171006181829 ACCESSION NUMBER: 0001065544-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171010 DATE AS OF CHANGE: 20171006 EFFECTIVENESS DATE: 20171010 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SEQUELLA INC. CENTRAL INDEX KEY: 0001065544 IRS NUMBER: 522044703 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-296216 FILM NUMBER: 171128294 BUSINESS ADDRESS: STREET 1: 9610 MEDICAL CENTER DR STREET 2: SUITE 200 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-762-7776 MAIL ADDRESS: STREET 1: 9610 MEDICAL CENTER DR STREET 2: SUITE 200 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SEQUELLA INC DATE OF NAME CHANGE: 19980708 D 1 primary_doc.xml X0708 D LIVE 0001065544 SEQUELLA INC. 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 301-762-7776 DELAWARE SEQUELLA INC Corporation true CAROL A. NACY 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 Executive Officer Director LEO EINCK 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 Executive Officer Director RONALD I. MELTZER 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 Director BRADLEY ROTTER 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 Director LAWRENCE MILLER 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 Executive Officer JOHN FRIEDMAN 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 Director PAIGE MACDONALD 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 Director MARK RAMPY 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 Executive Officer DAVID MCNEELEY 9610 MEDICAL CENTER DR SUITE 200 ROCKVILLE MD MARYLAND 20850 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2017-09-07 false true true false 25071 LAMPOST CAPITAL, L.C. 43706 DAVID N. OLSON 4765634 7777 W. GLADES ROAD, SUITE 213 BOCA RATON FL FLORIDA 33434 NY NEW YORK PR PUERTO RICO CO COLORADO FL FLORIDA CA CALIFORNIA false 3624753 630589 2994164 Offering amount includes warrant compensation noted in Item 15. false 6 42782 0 SALES COMMISSIONS PAID TO LAMPOST CAPITAL INCLUDE CASH PAYMENT OF $20,313.00, WARRANTS FOR COMMON STOCK SHARES WITH AN AGGREGATE EXERCISE PRICE OF $14,469.00 AND $8,000.00 IN EXPENSES 317000 Repayment of Notes. All noteholders whose notes were repaid with proceeds of the offering participated in the offering. false SEQUELLA INC. CAROL A. NACY CAROL A. NACY CEO 2017-10-06